heart palpitations semaglutide Why cardiologists may prescribe semaglutide and heart palpitations Effect

43 , e2021043 (2021)

Most patients describe this as mild to moderate in severity, occurring primarily during the first few weeks of treatment or after dose increases

Doses near the 30 mg mark are usually considered to be harmful

Medicines obtained through unregulated or unapproved sources will often not have been prescribed by a health professional, may not have been subject to the normal safety and quality controls on manufacture and, as such, may not be of the required quality or be of the nature described. Mr McKendry urged anyone who suspects a medicine has been falsified to speak to a pharmacist or GP and report it to the MHRAs Yellow Card system as well as the MRGs investigating team

In practical terms: once-daily SubQ injection of 12 mg is the most common protocol, prioritizing consistency over peak concentration

The short version: the combination appears safe for most patients, but your prescribing provider should know about both medications before you start either one